Lillian Werner

Lillian Werner

UNVERIFIED PROFILE

Are you Lillian Werner?   Register this Author

Register author
Lillian Werner

Lillian Werner

Publications by authors named "Lillian Werner"

Are you Lillian Werner?   Register this Author

65Publications

1861Reads

46Profile Views

Cardiac and genetic predictors of cardiovascular risk in patients with myelodysplastic syndromes.

Leuk Lymphoma 2019 May 23:1-5. Epub 2019 May 23.

c Center for Leukemia , Massachusetts General Hospital , Boston , MA , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428194.2019.1617863DOI Listing
May 2019

Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.

Prostate 2018 09 10;78(12):927-937. Epub 2018 May 10.

Division of Urology, Department of Surgery, Brigham Women's Hospital, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23650DOI Listing
September 2018

Dynamic changes in CCL3 and CCL4 plasma concentrations in patients with chronic lymphocytic leukaemia managed with observation.

Br J Haematol 2018 02 21;180(4):597-600. Epub 2016 Oct 21.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.14398DOI Listing
February 2018

Upper Tract Urothelial Carcinomas: Prognostic Factors and Outcomes in Patients With Non-Lymph Node Distant Metastasis.

Clin Genitourin Cancer 2017 12 2;15(6):e1089-e1094. Epub 2017 Aug 2.

Dana-Farber Cancer Institute, Boston, MA; Hospital De Mar Research Institute-IMIM, Barcelona, Spain. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2017.07.012DOI Listing
December 2017

Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications.

J Urol 2017 10 6;198(4):817-823. Epub 2017 May 6.

Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Cancer Center, Boston, Massachusetts; Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.04.102DOI Listing
October 2017

Efficacy of Therapies After Galeterone in Patients With Castration-resistant Prostate Cancer.

Clin Genitourin Cancer 2017 08 27;15(4):463-471. Epub 2016 Oct 27.

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2016.10.006DOI Listing
August 2017

Duration of Androgen Deprivation Therapy for High-Risk Prostate Cancer: Application of Randomized Trial Data in a Tertiary Referral Cancer Center.

Clin Genitourin Cancer 2016 08 17;14(4):e299-305. Epub 2015 Dec 17.

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.12.008DOI Listing
August 2016

Expression Levels of DNA Damage Repair Proteins Are Associated With Overall Survival in Platinum-Treated Advanced Urothelial Carcinoma.

Clin Genitourin Cancer 2016 08 24;14(4):352-9. Epub 2015 Dec 24.

Bladder Cancer Center, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2015.12.029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5508512PMC
August 2016

A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy.

J Clin Oncol 2016 06 4;34(16):1913-20. Epub 2016 Apr 4.

Rana R. McKay, Lillian Werner, Christopher J. Sweeney, Philip W. Kantoff, and Mary-Ellen Taplin, Dana-Farber Cancer Institute, Boston; Robert W. Ross, Bluebird Bio, Cambridge, MA; Amado J. Zurita and Hai T. Tran, MD Anderson Cancer Center, Houston, TX; Justine Y. Bruce, University of Wisconsin Carbone Cancer Center, Madison, WI; Michael A. Carducci, Johns Hopkins University; Arif Hussain, Greenebaum Cancer Center, Baltimore, MD; Mark N. Stein, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Elisabeth I. Heath, Karmanos Cancer Institute, Detroit, MI; and Philip W. Kantoff and Susan F. Slovin, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.65.3154DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5321094PMC
June 2016

Cell kinetic studies fail to identify sequentially proliferating progenitors as the major source of epithelial renewal in the adult murine prostate.

PLoS One 2015 29;10(5):e0128489. Epub 2015 May 29.

Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America; Harvard Medical School, Boston, Massachusetts, United States of America; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128489PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4449166PMC
March 2016

Phase 2 trial of sunitinib and gemcitabine in patients with sarcomatoid and/or poor-risk metastatic renal cell carcinoma.

Cancer 2015 Oct 8;121(19):3435-43. Epub 2015 Jun 8.

Kidney Cancer Center, The Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29503DOI Listing
October 2015

Controversial fluorescence in situ hybridization cytogenetic abnormalities in chronic lymphocytic leukaemia: new insights from a large cohort.

Br J Haematol 2015 Sep 1;170(5):694-703. Epub 2015 Jun 1.

Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bjh.13498DOI Listing
September 2015

GermLine Variation in Superoxide Dismutase-2 (SOD2) and Survival Outcomes After Radiation Therapy for Prostate Cancer: Results of a Test and Validation Set Analysis.

Clin Genitourin Cancer 2015 Aug 3;13(4):370-377.e1. Epub 2015 Jan 3.

Department of Epidemiology, Harvard School of Public Health, Boston, MA; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15587673140029
Publisher Site
http://dx.doi.org/10.1016/j.clgc.2014.12.018DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038132PMC
August 2015

Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.

JAMA Oncol 2015 Jul;1(4):495-504

Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts2Gelb Center for Translational Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoncol.2015.0829DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5554437PMC
July 2015

Lenalidomide and rituximab for the initial treatment of patients with chronic lymphocytic leukemia: a multicenter clinical-translational study from the chronic lymphocytic leukemia research consortium.

J Clin Oncol 2014 Jul 27;32(19):2067-73. Epub 2014 May 27.

Danelle F. James, Januario E. Castro, Andrew Greaves, Laura Z. Rassenti, Thomas J. Kipps, Moores Cancer Center, University of California San Diego, La Jolla, CA; Lillian Werner, Jennifer R. Brown, Donna Neuberg, Dana-Farber Cancer Institute, Boston, MA; William G. Wierda, MD Anderson Cancer Center, The University of Texas, Houston, TX; Jacqueline C. Barrientos, Kanti R. Rai, North Shore-Long Island Jewish Health System, New Hyde Park, NY; Amy J. Johnson, The Ohio State University, Columbus, OH.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2013.51.5890DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067945PMC
July 2014

Integrative analysis of 1q23.3 copy-number gain in metastatic urothelial carcinoma.

Clin Cancer Res 2014 Apr 31;20(7):1873-83. Epub 2014 Jan 31.

Authors' Affiliations: Departments of Biostatistics and Computational Biology, and Medical Oncology; Center for Molecular Oncologic Pathology, Dana-Farber Cancer Institute; Department of Biostatistics, Harvard School of Public Health; Department of Pathology; Translational Medicine Division, Brigham and Women's Hospital, Boston; Broad Institute of Harvard and MIT, Cambridge, Massachusetts; Sidney Kimmel Cancer Center; Department of Pathology, Johns Hopkins University, Baltimore, Maryland; Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York; and Hospital del Mar Research Institute-IMIM, Barcelona; and Hospital Parc Tauli, Sabadell, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0759DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975677PMC
April 2014

Aspirin use, 8q24 single nucleotide polymorphism rs6983267, and colorectal cancer according to CTNNB1 alterations.

J Natl Cancer Inst 2013 Dec 7;105(24):1852-61. Epub 2013 Dec 7.

Affiliations of authors: Division of Cancer Epidemiology, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD (HN); Channing Division of Network Medicine, Department of Medicine (HN, DJH, ELG, CSF, ATC) and Department of Epidemiology (DJH, PK, ELG, SO), Brigham and Women's Hospital and Harvard Medical School, Boston, MA; Center for Molecular Oncologic Pathology (TM, YI, AK, MY, SO), Department of Medical Oncology (TM, MS, YI, AK, MY, CSF, SO, MLF), and Department of Biostatistics and Computational Biology (LW), Dana-Farber Cancer Institute, Boston, MA; Department of Epidemiology (DJH, ELG, SO) and Department of Nutrition, Harvard School of Public Health, Boston, MA (DJH, ELG); Broad Institute, Program in Medical and Population Genetics, Cambridge, MA (MLF); Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA (ATC).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt331DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866156PMC
December 2013

Secondary hormonal therapy in men with castration-resistant prostate cancer.

Clin Genitourin Cancer 2011 Dec 29;9(2):95-103. Epub 2011 Sep 29.

Lank Center for Genitourinary Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney St., Boston, MA 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2011.06.006DOI Listing
December 2011

Phase II study of dasatinib in relapsed or refractory chronic lymphocytic leukemia.

Clin Cancer Res 2011 May 14;17(9):2977-86. Epub 2011 Mar 14.

Massachusetts General Hospital Cancer Center, Medical Oncology and Department of Biostatistics, Dana-Farber Cancer Institute, Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2879DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108904PMC
May 2011

Risk stratification and validation of prostate specific antigen density as independent predictor of progression in men with low risk prostate cancer during active surveillance.

J Urol 2011 Feb 17;185(2):471-6. Epub 2010 Dec 17.

Division of Urologic Surgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2010.09.115DOI Listing
February 2011

Predictors of survival in patients with prostate cancer and spinal metastasis. Presented at the 2009 Joint Spine Section Meeting. Clinical article.

J Neurosurg Spine 2010 Dec;13(6):789-94

Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3171/2010.6.SPINE10167DOI Listing
December 2010

Inherited variations in AR, ESR1, and ESR2 genes are not associated with prostate cancer aggressiveness or with efficacy of androgen deprivation therapy.

Cancer Epidemiol Biomarkers Prev 2010 Jul;19(7):1871-8

Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1055-9965.EPI-10-0216DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3755451PMC
July 2010

Using blocks of linked single nucleotide polymorphisms as highly polymorphic genetic markers for parentage analysis.

Mol Ecol Resour 2009 Mar 29;9(2):487-97. Epub 2008 Oct 29.

Centre for Mathematical Biology, Massey University, Private Bag 102-904, North Shore Mail Centre, Auckland 0745, New Zealand, Institute of Information and Mathematical Sciences, Massey University, Private Bag 102-904, North Shore Mail Centre, Auckland 0745, New Zealand, Dana Farber Cancer Research Center, Boston, MA 02115, USA, Department of Biological Sciences, Binghamton University, PO Box 6000, Binghamton, NY 13902, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1755-0998.2008.02444.x
Publisher Site
http://dx.doi.org/10.1111/j.1755-0998.2008.02444.xDOI Listing
March 2009